Your body is under constant attack. Every breath you take introduces hundreds of microorganisms. Every meal carries bacteria. Every cut exposes tissue to the outside world. Yet most of the time you stay healthy. The immune system is why.
Understanding the immune system means understanding two broad strategies: innate immunity (fast, non-specific, always ready) and adaptive immunity (slow, specific, improves with experience). Both work together, and the interface between them — how innate signals trigger adaptive — is where much of the interesting biology lies.
Key Terms & Definitions
Antigen: Any molecule (usually a protein or polysaccharide on a pathogen’s surface) that triggers an immune response. “Antigen” = “antibody generator.”
Antibody (immunoglobulin): A Y-shaped protein produced by plasma cells (activated B cells) that binds specifically to an antigen. Five classes: IgG, IgM, IgA, IgD, IgE.
Innate immunity: The non-specific first line of defence present from birth. Responds immediately but cannot adapt or improve over time.
Adaptive immunity: The specific, antigen-directed immune response. Slower (days), but highly targeted and develops immunological memory.
B lymphocytes (B cells): White blood cells that mature in the Bone marrow. When activated, differentiate into plasma cells (antibody factories) and memory B cells.
T lymphocytes (T cells): White blood cells that mature in the Thymus. Two main types: Helper T cells (CD4⁺) coordinate the immune response; Cytotoxic T cells (CD8⁺) directly kill infected cells.
MHC (Major Histocompatibility Complex): Surface proteins that display antigen fragments for T cell inspection. MHC class I on all nucleated cells; MHC class II on antigen-presenting cells (macrophages, dendritic cells).
Clonal selection: When an antigen activates a specific lymphocyte (B or T cell), that cell proliferates — making many identical copies (a clone) that are all specific to that antigen.
Memory cells: Long-lived B and T cells generated during the primary response. They persist for years/decades and enable the faster, stronger secondary response.
Complement system: A cascade of ~30 plasma proteins that, when activated, lyse pathogens, attract phagocytes, and enhance phagocytosis. Part of innate immunity but also triggered by antibodies.
Innate Immunity — The First Line of Defence
Innate immunity has two components: physical/chemical barriers and cellular/molecular responses.
Physical and Chemical Barriers
- Skin: Physical barrier that most pathogens cannot penetrate. Slightly acidic pH (~5.5) inhibits bacterial growth. Sebum (oil) and sweat contain antimicrobial peptides.
- Mucus: Lines respiratory, digestive, and urogenital tracts. Traps pathogens. Ciliated epithelium sweeps mucus (and trapped pathogens) upward to be swallowed or expelled.
- Tears, saliva, breast milk: Contain lysozyme — an enzyme that degrades bacterial cell walls (by breaking the peptidoglycan layer).
- Stomach acid (pH ~2): Destroys most ingested pathogens.
- Normal microbiota: The trillions of bacteria that normally colonise the gut, skin, and other surfaces compete with pathogens for nutrients and space, and produce antimicrobial substances.
Cellular Innate Immune Responses
When pathogens breach the barriers, pattern recognition receptors (PRRs) — including Toll-like receptors (TLRs) on immune cells — detect conserved molecular patterns on pathogens called PAMPs (Pathogen-Associated Molecular Patterns).
Key innate immune cells:
Neutrophils: Most abundant white blood cells. First responders — arrive at infection site within hours. Engulf and destroy pathogens via phagocytosis. Release toxic granules (neutrophil extracellular traps). Short-lived (die within hours of action — pus is largely dead neutrophils).
Macrophages: Tissue-resident phagocytes. Engulf and digest pathogens (phagocytosis). Also act as antigen-presenting cells (APCs) — they display antigen fragments on MHC class II, bridging innate and adaptive immunity. Produce pro-inflammatory cytokines (IL-1, TNF-α, IL-6) that signal other immune cells and cause fever.
Natural Killer (NK) cells: Lymphocytes that kill virus-infected cells and tumour cells without antigen specificity. They recognise cells with reduced MHC class I expression (a common strategy viruses use to hide from T cells).
Dendritic cells: The most potent APCs. Sample antigens in tissues, travel to lymph nodes, and present antigens to T cells, initiating the adaptive immune response.
Mast cells and basophils: Release histamine and other mediators during allergic reactions and parasitic infections.
Interferons: Proteins secreted by virus-infected cells that warn neighbouring cells to ramp up their antiviral defences.
Fever is an innate immune response. Macrophages release interleukin-1 (IL-1) and TNF-α when they encounter pathogens. These cytokines travel to the brain’s hypothalamus and raise the body’s temperature set-point. Higher temperatures inhibit viral and bacterial replication (they’re evolved for normal body temperatures) and speed up immune cell activities.
Adaptive Immunity — The Specific Strike Force
Adaptive immunity is activated by the innate immune system — specifically by antigen presentation from macrophages and dendritic cells. It takes several days to develop but is exquisitely specific and leaves lasting memory.
Humoral Immunity (B cells and Antibodies)
Process:
- A naïve B cell with an antigen-specific receptor encounters its matching antigen (often with help from helper T cells)
- The B cell is activated → undergoes clonal expansion (rapid division)
- Clones differentiate into plasma cells (antibody-secreting factories) and memory B cells
- Plasma cells secrete millions of antibodies per day into the bloodstream
How antibodies work:
- Neutralisation: Antibodies bind to the surface of viruses or bacteria, physically blocking them from entering host cells
- Opsonisation: Antibodies coat pathogens, making them easier for phagocytes to recognise and engulf (like putting a “eat me” flag on the pathogen)
- Complement activation: Antibodies (especially IgG and IgM) trigger the complement cascade when bound to pathogens
- Agglutination: Antibodies clump pathogens together, preventing spread and making phagocytosis easier
Immunoglobulin classes:
| Class | Location | Main Function |
|---|---|---|
| IgG | Blood, tissues | Major antibody of secondary response; crosses placenta (foetal immunity) |
| IgM | Blood | First produced in primary response; 5 Y-shapes bound together |
| IgA | Mucous secretions, saliva, breast milk | Defends mucosal surfaces |
| IgE | Associated with mast cells | Allergic reactions; antiparasitic |
| IgD | B cell surface | Role in B cell activation (not fully understood) |
Cell-Mediated Immunity (T cells)
Not all pathogens are accessible to antibodies — viruses hide inside cells. Cell-mediated immunity handles intracellular threats.
Process:
- Dendritic cells present antigen fragments (via MHC class II) to helper T cells (CD4⁺)
- Activated helper T cells release cytokines (interleukins, interferons) that amplify both humoral and cell-mediated responses
- Dendritic cells also present to cytotoxic T cells (CD8⁺) via MHC class I
- Activated cytotoxic T cells find and kill infected cells — they release perforin (punches holes in cell membrane) and granzymes (trigger apoptosis inside the cell)
T regulatory cells (Tregs): Suppress immune responses to prevent the immune system from attacking the body’s own tissues (autoimmunity prevention). Failure of Tregs → autoimmune diseases (rheumatoid arthritis, type 1 diabetes, lupus).
Remember the helper T cell / cytotoxic T cell distinction by the co-receptors: CD4⁺ cells “help” (they direct both humoral and cell-mediated immunity). CD8⁺ cells “kill” infected cells. In HIV infection, the virus specifically kills CD4⁺ helper T cells — destroying the coordinator of the entire adaptive immune response, which is why AIDS patients become vulnerable to opportunistic infections.
Primary vs Secondary Immune Response
| Feature | Primary | Secondary |
|---|---|---|
| Trigger | First exposure to antigen | Second exposure (same antigen) |
| Lag period | 1–2 weeks | 2–4 days |
| Antibody titre | Lower | 10–100× higher |
| Dominant Ig | IgM first, then IgG | Predominantly IgG |
| Duration | Shorter | Longer |
| Memory cells | Generated for the first time | Already present, reactivated |
The secondary response is faster and stronger because memory cells are already present in large numbers with high antigen-specificity and low activation threshold.
This is the biological basis for vaccination — vaccines stimulate the primary response and generate memory cells, so the secondary response is ready when the real pathogen arrives.
Types of Immunity
| Type | How Acquired | Example | Duration |
|---|---|---|---|
| Natural Active | Natural infection | Surviving measles | Long-lasting |
| Artificial Active | Vaccination | MMR vaccine | Long-lasting |
| Natural Passive | Maternal antibodies (via placenta or breast milk) | IgG to newborn | Temporary (few months) |
| Artificial Passive | Injection of antibodies/antiserum | Anti-tetanus serum | Temporary (weeks) |
Active immunity: Body makes its own antibodies (takes time, lasts long). Passive immunity: Ready-made antibodies given (immediate effect, short-lived as the antibodies are eventually broken down).
Allergies and Autoimmunity
Allergies (Hypersensitivity)
An allergy is an exaggerated immune response to a normally harmless antigen (called an allergen — pollen, dust mites, peanuts, etc.).
Process: First exposure → IgE antibodies produced → IgE binds to mast cells. Second exposure → allergen binds IgE on mast cells → mast cells degranulate (release histamine, leukotrienes) → vasodilation, mucus production, bronchoconstriction → allergy symptoms.
Anaphylaxis: A severe, systemic allergic reaction — massive histamine release causes a dangerous drop in blood pressure and airway constriction. Treated with adrenaline (epinephrine) injection.
Autoimmune Diseases
When the immune system fails to distinguish self from non-self and attacks the body’s own tissues. Examples:
- Rheumatoid arthritis: Immune attack on joint tissues
- Type 1 diabetes: Immune attack on insulin-producing beta cells in the pancreas
- Lupus: Widespread attack on multiple organs
- Multiple sclerosis: Attack on the myelin sheath of neurons
Solved Examples
Example 1 — CBSE Level
Q: Why does a second infection with the same pathogen usually cause less illness than the first?
A: During the first infection (primary response), memory B and T cells are generated. These memory cells persist long after the pathogen is cleared. During the second infection, memory cells respond immediately — clonal expansion begins within 2–4 days instead of 1–2 weeks. Antibodies reach high titres before the pathogen can multiply to disease-causing levels. The infection is typically cleared before symptoms develop, or symptoms are much milder.
Example 2 — NEET Level
Q: A newborn baby is protected against many diseases even without being vaccinated. Explain.
A: A newborn receives natural passive immunity in two ways:
- Placental transfer: IgG antibodies from the mother cross the placenta during the last trimester. At birth, the newborn’s IgG levels are similar to or even higher than the mother’s.
- Breast milk: Colostrum (first milk) is particularly rich in secretory IgA and other immune factors. IgA coats the baby’s gut lining, protecting against intestinal pathogens.
This passive immunity wanes over 3–6 months as maternal antibodies are broken down. This is why infant vaccination schedules begin at 6–8 weeks — to build the baby’s own active immunity before maternal protection fades.
Example 3 — Challenging
Q: HIV destroys helper T cells. Explain why this leads to vulnerability to opportunistic infections.
A: Helper T cells (CD4⁺ cells) are the central coordinators of the adaptive immune response. They:
- Activate B cells (→ antibody production / humoral immunity)
- Activate cytotoxic T cells (→ killing of infected cells / cell-mediated immunity)
- Produce cytokines that enhance macrophage activity
- Help activate NK cells
Without helper T cells, neither humoral nor cell-mediated immunity can function effectively. Naïve B cells receive insufficient help signals and don’t differentiate into plasma cells — antibody production collapses. Cytotoxic T cells remain inactive without helper T cell support — infected cells go unkilled.
HIV patients become vulnerable to “opportunistic infections” — pathogens like Pneumocystis jirovecii (causes a type of pneumonia), Toxoplasma gondii, Candida albicans (fungal infections) — that a normal immune system would easily control but an HIV-compromised immune system cannot.
Common Mistakes to Avoid
Mistake 1 — B cells and T cells come from different places: B cells mature in the Bone marrow (B for bone). T cells mature in the Thymus (T for thymus). Both originate from stem cells in the bone marrow but T cell precursors migrate to the thymus to mature. This distinction is essential.
Mistake 2 — Antibodies kill pathogens directly: Antibodies alone don’t usually “kill” pathogens — they mark them (opsonisation), neutralise them (blocking entry to cells), or trigger complement/phagocytosis. The actual killing is done by phagocytes (for bacteria) or by the complement system.
Mistake 3 — Active vs passive confusion in exams: The quick rule — if the immune system makes its own antibodies = active (long-lasting). If antibodies are given from outside = passive (short-lasting). Vaccination = active (body makes antibodies). Antiserum/antitoxin injection = passive (ready-made antibodies).
Mistake 4 — IgM vs IgG in primary vs secondary response: IgM is the first immunoglobulin produced in the primary response (pentameric, very large, stays in blood). IgG is the dominant antibody in the secondary response (smaller, crosses placenta, most abundant in blood). Exams often ask which antibody predominates in secondary response — answer: IgG.
Practice Questions
Q1: Distinguish between innate and adaptive immunity.
Innate immunity is present from birth, non-specific, acts immediately, and doesn’t improve with each exposure. It includes physical barriers (skin, mucus), phagocytic cells (neutrophils, macrophages), NK cells, complement system, and interferons.
Adaptive immunity is specific to individual antigens, takes days to develop on first exposure, and improves with repeated exposure (immunological memory). It involves B cells (antibody production) and T cells (cell-mediated killing and coordination). Adaptive immunity is activated by signals from the innate immune system.
Q2: What is the role of helper T cells in the immune response?
Helper T cells (CD4⁺) are the central coordinators of the adaptive immune response. They are activated when antigen-presenting cells (macrophages, dendritic cells) display antigen fragments via MHC class II molecules. Activated helper T cells then: (1) release cytokines (especially interleukins) that stimulate B cell activation and antibody production; (2) help activate cytotoxic T cells for cell-mediated immunity; (3) enhance macrophage killing ability. Without helper T cells, neither humoral nor cell-mediated adaptive immunity functions properly — as demonstrated by AIDS (HIV kills CD4⁺ cells).
Q3: Explain the concept of clonal selection.
The body has millions of different B and T lymphocytes, each with a unique antigen receptor recognising a different antigen. When a specific antigen enters the body, it selects and binds to the few lymphocytes with matching receptors. This binding activates those lymphocytes to divide rapidly — producing a large clone of cells all specific for that antigen (clonal selection and expansion). Some clones become effector cells (plasma cells, cytotoxic T cells) that fight the current infection; others become memory cells that persist long-term.
Q4: Why must flu vaccines be updated every year but the polio vaccine lasts a lifetime?
The influenza virus mutates its surface proteins (haemagglutinin and neuraminidase) rapidly through antigenic drift (minor mutations each year) and antigenic shift (major recombination events). Memory cells generated against last year’s flu surface proteins don’t recognise the new variant’s changed surface proteins — so protection wanes.
Polio virus has a stable protein coat — its surface antigens don’t change significantly over time. Memory cells generated by the polio vaccine recognise the same antigens decades later. One or two doses provide lifelong protection.
FAQs
Q: Can the immune system attack the body’s own cells? Yes — this is autoimmunity. Normally, T cells that react to self-antigens are eliminated in the thymus (central tolerance) and peripheral tolerance mechanisms suppress those that escape. When these mechanisms fail, autoimmune diseases develop. Examples include rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and systemic lupus erythematosus.
Q: What causes an allergic reaction? Allergies occur when IgE antibodies specific to a harmless allergen (pollen, peanuts, pet dander) are produced. IgE binds to mast cells in tissues. On re-exposure, the allergen cross-links IgE on mast cells, triggering degranulation — release of histamine, leukotrienes, and prostaglandins. These mediators cause vasodilation, increased vascular permeability, mucus secretion, and bronchoconstriction — the symptoms of allergy.
Q: How does the immune system “know” not to attack food antigens? The gut-associated lymphoid tissue (GALT) actively promotes tolerance to food antigens through regulatory T cells. This oral tolerance mechanism ensures that food proteins don’t trigger damaging immune responses. When this tolerance breaks down, food allergies or conditions like coeliac disease (immune reaction to gluten) can develop.
Q: Why don’t cancer cells get destroyed by the immune system? They often do — but cancer cells evolve strategies to evade immunity: reducing MHC class I expression (hiding from cytotoxic T cells), expressing PD-L1 (a protein that switches off T cell activity), secreting immunosuppressive cytokines, and other mechanisms. Modern cancer immunotherapy (checkpoint inhibitors like pembrolizumab) works by blocking PD-L1/PD-1 signalling, allowing T cells to recognize and kill cancer cells again.